 Lifespan.io has recently launched a new crowdfunding campaign to support longevity research. The new campaign will be funding a large human trial, the Participatory Evaluation of Aging with Rapamycin for Longevity Study or PERL. Rapamycin is a drug well known for its longevity benefits and mice and this trial aims at finding out whether there's similar benefits in humans. The trial will follow up to 200 participants over 12 months testing four different rapamycin dosing regimens. It will be double-blind, randomized, placebo-controlled, and registered with clinicaltrials.gov. Follow the link in the description below to learn more and make a donation. See the full video at youtube.com backslash x10show